Yasir Elamin, M.D.
NPI 1073979035ActiveIndividual· Internal Medicine, Medical Oncology· Houston, TX
Internal Medicine, Medical Oncology (M.D.) with Physicians Referral Service, practicing in Houston, Texas. Their prescriptions cost Medicare Part D more than their services did: $1,935,988 for 230 claims, against $39,389 paid for services in 2024. Takeda Pharmaceuticals U.S.A., Inc. was the largest of 4 companies reporting payments in 2025, $6,782 in all, mostly consulting fees.
Overview
| NPI | 1073979035 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Jan 6, 2016 |
| Last updated in NPPES | Jan 11, 2022 |
| Certified by provider | Jan 11, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | T2362 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 174 |
|---|---|
| Services billed | 439 across 11 procedure codes |
| Paid by Medicare | $39,389 |
Part D prescriptions in 2024
| Prescriptions (claims) | 230 · 253 30-day fills |
|---|---|
| Patients | 60 |
| Total drug cost | $1,935,988 |
| Generic share | 57% of claims |
Education and affiliations
| Graduation year | 2005 |
|---|---|
| Medicare specialty | Medical Oncology |
| Telehealth | Offers telehealth |
Medical group
- Physicians Referral ServiceHouston, TX · 2,765 clinicians
Industry payments (Open Payments)
- 2025$6,782 · 9 payments from 4 companies
- 2024$14,035 · 16 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $3,146 | 3 |
| Astrazeneca Pharmaceuticals LP | $1,809 | 3 |
| Janssen Biotech, Inc. | $1,708 | 2 |
| Rigel Pharmaceuticals, Inc. | $119.70 | 1 |
What the 2025 payments were for
- Consulting Fee$6,408 · 3 payments
- Food and Beverage$319.16 · 5 payments
- Travel and Lodging$55.51 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Medical Oncology providers in Houston
- 1144581067
- 1659324093
- 1427067479
- 1023189685
- 1962419804
- 1134233224
- 1518227735
- 1205097599
- 1215123971
- 1285846790
- 1124107156
- 1518059898
All Internal Medicine, Medical Oncology providers in Texas →